Delivery Order SPE2DB22D3102-SPE2DB25FL2XK
- Not listed
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $7,581.86 to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count units). This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets (60-count) under a firm fixed-price contract valued at $2,186.98. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location....
- The Defense Logistics Agency awarded a $1,387.02 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 2 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Risperidone 1 mg ODT (orally disintegrating tablet) in unit dose packaging, 30-count quantities. This is a firm fixed-price delivery order with a ceiling value of $1,780.96 and an ultimate completion date of July 22, 2025. The contract is non-set-aside and represents a competitive award. Performance will take place at AmerisourceBergen's corporate office...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,434.33 contract is for the delivery of 60 tablets of the drug Risperdal 1 mg. The order has a completion date of January 22, 2024. This delivery order is part of AmerisourceBergen Drug Corp's existing contractual relationship with DLA Troop Support Medical to provide...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2XKDelivery Order
The Defense Logistics Agency awarded a $3,953.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count) on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's established role as a primary pharmaceutical vendor supporting the Defense Health Agency and other federal healthcare systems. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitively awarded contracts through this vehicle demonstrates the company's capability to meet federal procurement requirements for critical pharmaceutical supplies supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/9/25 |